<DOC>
	<DOC>NCT00139724</DOC>
	<brief_summary>To evaluate efficacy of tolterodine extended release formulation compared with immediate release formulation in subjects with symptoms of overactive bladder</brief_summary>
	<brief_title>Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Subjects with a diagnosis of overactive bladder. Subjects with significant stress incontinence as determined by the investigator. Subjects with recurrent urinary tract infections defined as treated for UTI; 5 times in the last year.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>